Posted on 7/7/20
Cel-Sci Management May Not Be As Confident In Multikine As They Appear To Be
SummaryIn recent presentations, Cel-Sci portrays its insiders as buying shares in the lead up to Phase 3 Multikine trial results, implying confidence in the ongoing Phase . . .
Posted on 5/24/20
Cel-Sci: A Zombie Biotech Company
Before laying out my short thesis on Cel-Sci (CVM) I need to make one disclosure. In 2018 I wrote an article for the long side which . . .
Posted on 5/15/18
Cel-Sci: Simple Math Appears To Imply Phase 3 Success
Cel-Sci Corporation is currently testing Multikine (Leukocyte Interleukin) as a potential first-line therapy in patients with squamous cell carcinoma of the head and neck. Head and . . .
Philadelphia
